ZORYVE cream, 0.3%, is indicated for topical treatment of plaque psoriasis, including intertriginous areas, in adult and pediatric patients 6 years of age and older. ZORYVE cream, 0.15%, is indicated ...

Various systemic therapies for psoriasis either reduced, slightly increased or had no effect on risk for major adverse ...

Bimekizumab use for 4 years among patients with plaque psoriasis is associated with sustained efficacy outcomes and no new safety signals.

Japanese researchers trained an AI model to rate atopic dermatitis severity from patient-taken photos, showing 98% ...

Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved ...

There are many other types of rashes with a wide variety of causes. Treatment for a rash requires the correct diagnosis and can include medication and avoiding potential triggers.  Easily ...

Scalp psoriasis poses unique challenges for people of color, including misdiagnosis, treatment access barriers, and lack of representation in medical education. Dr. Mona Shahriari, the senior editor ...

Abdominal obesity is a greater risk factor for psoriasis than total body fat, according to an analysis of imaging data, ...

The latest update atopic dermatitis guidelines include the new approval of lebrikizumab and the expanded use of baricitinib ...

For individuals with rosacea, stress and the accompanying rise in neuropeptides can lead to facial redness, flushing, and the ...

VedicDerm launches a steroid-free Ayurvedic psoriasis cream, scientifically proven to reduce inflammatory markers by up to 99 ...

Symptoms, lesion locations, and morphology are among the features clinicians may use to distinguish hand eczema from hand psoriasis in patients.